• Concord Healthcare Group set to issue HK$ 68 million of 2% convertible bonds due 2027 via placing and subscription agreement signed May 10.
• Subscriber Dragon Merit Holdings, wholly owned by CSPC Pharmaceutical Group, to subscribe at 100% of principal on closing date May 13.
• Bonds convertible into H shares at initial conversion price HK$ 1.7, implying up to 40,000,000 new H shares on full conversion.
• Net proceeds estimated at about HK$ 63.1 million, earmarked mainly for loan repayment, remainder for working capital.
• No listing planned for bonds; listing application to be made for conversion shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Concord Healthcare Group Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260511-12154228), on May 11, 2026, and is solely responsible for the information contained therein.